Ventilator-associated Pneumonia Prevention in the Intensive Care Unit Using Postpyloric Tube Feeding in China (VIP Study): Study Protocol for a Randomized Controlled Trial
Overview
Pharmacology
Authors
Affiliations
Background: Ventilator-associated pneumonia is a challenge in critical care and is associated with high mortality and morbidity. Although some consensuses on preventing ventilator-associated pneumonia are reached, it is still somewhat controversial. Meta-analysis has shown that postpyloric tube feeding may reduce the incidences of ventilator-associated pneumonia, which still desires high-quality evidence. This trial aims to evaluate the efficacy and safety profiles of postpyloric tube feeding versus gastric tube feeding.
Methods/design: In this multicenter, open-label, randomized controlled trial, we will recruit 924 subjects expected to receive mechanical ventilation for no less than 48 h. Subjects on mechanical ventilation will be randomized (1:1) to receive postpyloric or gastric tube feeding and routine preventive measures simultaneously. The primary outcome is the proportion of patients with at least one ventilator-associated pneumonia episode. Adverse events and serious adverse events will be observed closely.
Discussion: The VIP study is a large-sample-sized, multicenter, open-label, randomized, parallel-group, controlled trial of postpyloric tube feeding in China and is well-designed based on previous studies. The results of this trial may help to provide evidence-based recommendations for the prevention of ventilator-associated pneumonia.
Trial Registration: Chictr.org.cn ChiCTR2100051593 . Registered on 28 September 2021.
Xuefen Z, Yuanyuan B, Qin L, Xiaoyang W Wideochir Inne Tech Maloinwazyjne. 2024; 18(4):625-638.
PMID: 38239578 PMC: 10793145. DOI: 10.5114/wiitm.2023.130468.